Press Releases

AMRI Leads the Industry in Highest Ranking from SafeBridge for Highly Potent Compound Safety

AMRI's Rensselaer, NY facility is the first in the industry to achieve Leader Status based on quantitative results of the Potent Compound Safety Certification program administered by SafeBridge.

Profacgen Introduced Trimeric Protein Production Service for Protein Research Field

Elsevier adds to its extensive free resources for biomedical and scientific researchers working on coronavirus with access to broad suite of tools

The Elsevier Coronavirus Research Hub includes access to multiple tools, from scientific and clinical content to COVID-19 specific datasets, text mining services and more

BioIVT Opens New Blood Donor Center to Support Boston-area Research into COVID-19 Therapies, Vaccines and Diagnostics

Located on the Tufts University Medford, MA campus, this new donor center will enable delivery of fresh blood, leukopaks and buffy coats for COVID-19, cell and gene therapy research within hours of collection.

CluePoints Launches Complimentary COVID-19 Risk Management Package for Clinical Studies

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that it has launched a complimentary COVID-19 risk management package available to all at no cost. With the FDA, EMA, PMDA and MHRA issuing specific guidelines as a result of the coronavirus, the CluePoints package will help meet these new recommendations and address additional study risks. The platform includes a widely used online Risk Assessment and Control solution that can be leveraged for performing risk planning and mitigation activities addressing inherent risks during this crisis. Register here for the COVID-19 risk management package.

Independent Site Management Organisation Panthera prepares for COVID-19

Independent Site Management Organisation Panthera is working with sponsors who need to press ahead with trials which can be done safely.

Sharp Clinical Supports Development of Novel COVID-19 Vaccines and Treatments

Sharp Clinical, part of UDG Healthcare and a leading provider of global clinical supply services, has confirmed that it is involved in supporting six clinical trials related to COVID-19.

New Study Finds Global Clinical Trial Sites Continue to Face Financial Constraints, Directly Impacting Study Efficiencies

As Universities and Academic Institutions Face Unique Challenges in Reporting Clinical Trials, TrialAssure Responds by Offering Free Clinical Trial Transparency Tool

TrialAssure® announced today that it will offer academic institutions free access to TrialAssure REGISTRY—the premiere clinical trial disclosure reporting application.

Greenphire Launches Extension of its ConneX Solution, ConneX Patient Direct, as Trial Sites Seek Support in Response to COVID-19

Clinical Ink Donates Mobile Devices to Aid in Mental Tele-Health

Clinical Ink, a global clinical trial technology company, has made a commitment to donate several hundred mobile phones and tablets to Thrive Behavioral Health for individual and family mental tele-health services, which are largely replacing in-person sessions during the COVID-19 crisis.

Clinically-proven gamification app teaches positive inhaler technique; crucial for managing asthma

A newly validated app called Rafi-Tone, developed by clinicians in the UK, makes using an inhaler with a spacer easier and more fun for young children with wheeze or asthma symptoms.

Biological Specialty Company Launches At-home Blood Donation Service for COVID-19 Patients Who Want to Help Develop New Drugs and Vaccines

BSC is collecting blood samples from sick and recovered COVID-19 patients to assist in developing COVID-19 therapies, vaccines and diagnostic biomarkers.

ERT’s At-Home Cardiac Safety Assessment Ensures Clinical Trial Continuity

Company’s expertise, infrastructure and flexibility enable remote ECG assessment for fast-tracked COVID-19 vaccines /therapies and other critical pharmaceuticals

CD Bioparticles Announces Carbon-based Nanocages Production Services for Researchers

CD Bioparticles introduces carbon-based nanocages production services to global researchers.

PHARMASEAL Supports Life Science Businesses by Offering No Cost CTMS for COVID-19 Clinical Trials

PHARMASEAL International, provider of clinical trials management systems has today announced that it will offer the Engility® CTMS solution at no cost for COVID-19 Coronavirus clinical trials. The free offer to utilize Engility CTMS is open to biopharmaceutical organizations and academic institutions.

ERT Enables Clinical Trial Continuity through At-Home Respiratory Solutions

High-quality clinician-administered data collected during patient home visits advances respiratory trials throughout COVID-19 pandemic

Serimmune Announces Achievement of Research Milestone in Discovery and Development Collaboration with Merck

Serimmune, a leader in understanding the functional antibody repertoire’s role in human disease, today announced that the company has received a research milestone payment from Merck (known as MSD outside the United States and Canada) under its ongoing discovery and development collaboration agreement.

Zymewire Launches Directory Of Drug Development Experts With Services Available To Fight COVID-19

Zymewire announces the launch of CovidCollaborators.org, an online directory of expert, pro-bono, and discounted clinical development services being offered in the fight against COVID-19.

Noxopharm Investigating Potential COVID-19 Treatment

Noxopharm has identified a clinical trial opportunity that could help reduce the mortality rate of COVID-19.